Human Liver Cells Expressing Albumin and Mesenchymal Characteristics Give Rise to Insulin-Producing Cells by Meivar-Levy, Irit et al.
Hindawi Publishing Corporation
Journal of Transplantation
Volume 2011, Article ID 252387, 12 pages
doi:10.1155/2011/252387
Research Article
Human Liver CellsExpressingAlbuminandMesenchymal
CharacteristicsGive Riseto Insulin-ProducingCells
Irit Meivar-Levy,1 Tamar Sapir,2 Dana Berneman,1,3 Tal Weissbach,4 Sylvie Polak-Charcon,5
PhilippeRavassard,6 AndreasG.Tzakis,7 EytanMor,8 CamilloRicordi,2 andSarahFerber1,3
1Sheba Regenerative Medicine, Stem cells and Tissue engineering Center, Sheba Medical Center, Tel-Hashomer 52621, Israel
2Diabetes Research Institute, University of Miami Leonard M. Miller School of Medicine, 1450 NW 10th Avenue, Miami,
FL 33136, USA
3Department of Human Genetics and Molecular Medicine, Sackler School of Medicine, Tel-Aviv University, 69978 Tel-Aviv, Israel
4Obstetrics and Gynecology Department, Sapir Medical Ctrter 44281 Kfar Saba, Israel
5The Institute for Pathology, Sheba Medical Center, 52621 Tel-Hashomer, Israel
6BiotechnologyandBiotherapyGroup,CentredeRecherche,InstitutduCerveauetdelaMoelleCNRSUMR7225,INSERMUMRS795,
Universit´ e Pierre et Marie Curie, 75005 Paris, France
7The Miami Transplant Institute, University of Miami Leonard M. Miller School of Medicine, 1450 NW 10th Avenue, Miami,
FL 33136, USA
8Rabin Medical Center, Beilinson Campus, 49100 Petah-Tiqva, Israel
Correspondence should be addressed to Sarah Ferber, sferber@sheba.health.gov.il
Received 28 April 2011; Accepted 5 June 2011
Academic Editor: Thierry Berney
Copyright © 2011 Irit Meivar-Levy et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Activation of the pancreatic lineage in the liver has been suggested as a potential autologous cell replacement therapy for diabetic
patients. Transcription factors-induced liver-to-pancreas reprogramming has been demonstrated in numerous species both in
vivo and in vitro. However, human-derived liver cells capable of acquiring the alternate pancreatic repertoire have never been
characterized. It is yet unknown whether hepatic-like stem cells or rather adult liver cells give rise to insulin-producing cells.
Using an in vitro experimental system, we demonstrate that proliferating adherent human liver cells acquire mesenchymal-like
characteristics and a considerable level of cellular plasticity. However, using a lineage-tracing approach, we demonstrate that
insulin-producing cells are primarily generated in cells enriched for adult hepatic markers that coexpress both albumin and
mesenchymalmarkers.Takentogether,ourdatasuggestthatadulthumanhepatictissueretainsasubstantiallevelofdevelopmental
plasticity, which could be exploited in regenerative medicine approaches.
1.Introduction
A cure for type 1 diabetes mellitus depends on replenishing
functional insulin-producing cells. However, the limited
supply of pancreatic islets from cadaver donors and the
need for life-long immune suppression makes pancreas or
pancreatic islet allotransplantation impractical for the vast
majority of patients. This hurdle has led to a search for
new alternate sources of insulin-producing cells or tissues
[1–3]. A challenging approach to generating surrogate β-
cells for cell replacement therapy in diabetes is the direct
reprogramming of liver cells into insulin-producing cells.
Liver and pancreatic cells share a common developmental
origin, making liver cells good candidates for manipulation
into β-like cells [4]. Both tissues may share a common
population of progenitor cells [5]. For example, cells with
properties virtually identical to those of hepatic oval cells
can also emerge in the pancreas, especially after the ablation
of acinar cells [6]. Upon transplantation, these pancreas-
derived oval cells can diﬀerentiate into functional hepa-
tocytes and bile ducts [7]. The reciprocal conversion of
rodent [8–13]a n dh u m a n[ 14–18] liver cells into pancreatic
endocrine cells by transdiﬀerentiation or direct cellular
reprogramming has also been described. Liver cells have2 Journal of Transplantation
been induced to diﬀerentiate into insulin-producing cells by
ectopic expression of pancreatic transcription factors, the
best studied of which is PDX-1, a key regulator of pancreatic
development and insulin expression in adult pancreatic beta
cells [8, 10, 14, 16–19]. However, whether transcription
factor-induced reprogramming primarily occurs in “stem-
like” pluripotent cells or rather adult cells can directly give
rise to committed cells of alternate lineages is questionable
and presently analyzed.
Adult liver contains several populations of cells, includ-
inghepatocytes,cholangiocytes,endothelialstellatecells,and
bone marrow- (BM-) derived cells [20–22]. Activation of
the pancreatic lineage in mice in vivo has been reported to
occur in several areas of the intact organ [8, 11, 23, 24].
PDX-1-induced insulin production in mouse livers in vivo
appears to occur mainly in the parenchyma of the liver
around the central veins [8, 11, 25]. On the other hand,
NEUROD1 and betacellulin-induced insulin production
occurs mainly in cells close to the hepatic capsule [24].
NGN-3 and betacellulin induce the transdetermination of
parenchymal hepatocytes and hepatic progenitor cells and
possibly endoderm-derived oval cells in periportal areas of
the liver [26].
The aim of the present study was to characterize the
human-derived liver cells capable of giving rise to insulin-
producing cells and determine whether they originate from
mature or hepatic progenitor cells. The deﬁnite character-
istics of hepatic progenitor cells which populate the adult
human organ is controversial; however, there is a wide agree-
ment that all these populations express the epithelial marker,
EpCAM [27–29]. We generated in vitro primary cultures of
liver cells derived from diﬀerent human donors that already
demonstrated a capacity to reprogram along the endocrine
pancreatic and β-cell-like lineages by ectopic expression of
pancreatic transcription factors [14–16, 30]. The origin of
the induced insulin-positive cells in proliferating cultures of
adult human liver cells is not clear, because the original liver
cellmorphologyisalteredandthecellsundergomassiveded-
iﬀerentiation, which is further augmented by ectopic PDX-
1 expression and the reprogramming process itself [30].
Here, we characterize the cells in the adherent, proliferating
cultures derived from adult human liver and demonstrate
their mesenchymal-like characteristics. Using a genetic cell
lineage tracing for albumin, we demonstrate that the cells
coexpress both mesenchymal and adult hepatic markers, but
none of the cells express EpCAM. The mesenchymal-like
cells that originate from cells expressing albumin give rise to
insulin expression upon ectopic PDX-1 expression.
2.MaterialandMethods
2.1. Human Liver Cells. Adult human liver tissues were
obtained from 3 diﬀerent liver transplantation surgeries
from 4–10-years-old children and 8 individuals over forty
years old. Liver tissues were used with approval from the
Committee on Clinical Investigations (institutional review
board).
Isolation of human liver cells was performed as previ-
ously described [16, 31]. Brieﬂy, the cells were digested by
0.03% Collagenase type I (Worthington Biochemical Corp.,
NJ) and cultured in Dulbecco’s minimal essential medium
(1gr/L glucose) supplemented with 10% FCS, 100U/mL
penicillin, 100μg/mL streptomycin and 250ng/mL ampho-
tericin B (Biological Industries, Israel). The medium was
changed daily during the ﬁrst three days in order to remove
nonadherent cells. Ninety percent conﬂuent cultures were
split using trypsin-EDTA. The cells were kept at 37◦Ci na
humidiﬁed atmosphere of 5% CO2 and 95% air.
2.2.LentivirusVectorConstructionandVirusProduction. The
pTrip albumin promoter (410) nlsCRE DeltaU3 (ALB-Cre)
vector was generated by removing with BamHI and XhoIo f
theenhancedgreenﬂuorescentprotein(eGFP)codingregion
from the pTrip ALB eGFP DeltaU3 vector, which contains
a fragment of the rat albumin promoter from −423 to −23
relativetothetranscriptionstartsite.Theresultinglinearized
plasmid was blunt-ended with DNA polymerase I Klenow
fragment. The reading frame A Gateway cassette (Gateway
Conversion kit; Invitrogen) was next ligated to the blunt-
ended vector according to the manufacturer’s instructions,
generating a pTrip ALB rfa-Gateway DeltaU3 destination
vector. The nlsCRE fragment was ampliﬁed by PCR from
a plasmid [32]p r o v i d e db yG u i l a nV o d j d a n i( H o s p i t a ld e
la Pitie , Salpetriere, Paris) using the forward primer 5 
CACCAGATCTATGCCCAAGAAGA.
AGAGG-3  and the reverse primer 5 -CTCGAGCTA-
ATCGCCATCTTC-3 , and the resulting PCR product was
cloned into the pENTR/D/TOPO plasmid (Invitrogen) to
generate an nls-CRE entry clone. Both destination vector
a n de n t r yc l o n ew e r eu s e df o rin vitro recombination
using the LR clonase II system (Invitrogen) according to
the manufacturer’s instructions. The reporter vector was
constructed as previously reported [33].
Virus particles were produced in 293T cells after
pCMVdR8.91 and pMD2.G vectors cotransfection. The
culture medium was harvested 36–48h later.
2.3. Viral Infection. Lentiviruses infection was performed 24
hours after plating; liver cells were washed with PBS and
infected with a 1:1 mixture of the two viruses at multiplicity
of infection (MOI) 3:1 in growth media containing 8ng/mL
polybrene overnight. The medium was then replaced with
culture medium, and the cells were refed twice a week
and split 1:3 once a week. The percentiles of eGFP and
DsRed2positivecellswereanalyzedusingaBeckmanCoulter
FC500 ﬂow cytometer or FACS Calibur, using the CellQuest
program.
Adenoviral infection of Ad-CMV-PDX-1 (1000 MOI)
was preformed as previously reported [14, 16, 30].
2.4.AnimalStudies. Allanimalsweremaintainedandanimal
experiments were carried out under the supervision and
guidelines of the Sheba Medical center Institutional Animal
Welfare Committee (177/2002).
Cells at passage 4, were harvested, washed twice with
sterile PBS, counted, and resuspended in Matrigel (BD
Biosciences). Six-week-old female athymic nude mice wereJournal of Transplantation 3
injected subcutaneously in both ﬂanks with human liver
cells at density of 1 × 106 viable cells/100μL as previously
described [34]. Five mice were used in each group. Tumor
size was measured with a linear caliper for up to 17 weeks.
2.5. Flow Cytometry. Liver-derived cells were harvested and
washed with ﬂow cytometry buﬀer consisting of 1% BSA
and 0.1% sodium azide (Sigma, St. Louis, Mo,USA) in
phosphate buﬀered saline (Invitogen, Carlsbad, Calif,USA).
Forthecellsurfaceantigendetection,approximately105 cells
labeledwithconjugatedmonoclonalantibodies.Intracellular
staining was preformed using Intracellular Staining Flow
Assay Kit (Imgenex, San Diego, Calif, USA) following man-
ufacturer’s instruction. Control samples included unstained
cells,isotypeantibodystainedcells,andsingleﬂuorochrome-
stained cells. The antibodies used in this study are listed in
supplemental material data 1.
The cells were analyzed using a Beckman Coulter FC500
ﬂow cytometer or FACS Calibur, using the CellQuest pro-
gram.
2.6. Cell Sorting. Three weeks after lentiviruses infection the
labeled liver-derived cells were sorted using a ﬂuorescence-
activated cell sorter (FACS) (Aria cell sorter; Becton Dickin-
son, San Jose, Calif,USA) with a ﬂuorescein isothiocyanate
ﬁlter (530/30nm) for eGFP and a Pe-Texas Red ﬁlter
(610/20nm) for DsRed2.
2.7. In Vitro Adipogenic and Osteogenic Diﬀerentiation. Fol-
lowing manufacturer’s instructions (Human Mesenchymal
Stem Cell Functional Identiﬁcation Kit, R&D Systems, Min-
neapolis, Minn, USA), human liver-derived cells at passage
4 were plated on cover slips at 2,000cells/cm2 in 6-well
tissue culture-treated plates in the presence of the adipogenic
or osteogenic supplements provided by the company. The
appropriate supplemented medium was changed twice per
week. After 14 days in culture, the adipogenic culture formed
adipogenic-like vacuoles. The plates were ﬁxed with 4%
paraformaldehyde for 20 minutes and stained with Oil Red
O( Sigma). The osteogenic diﬀerentiation cultures were
incubated for 21 days and ﬁxed and stained with 1% Alizarin
Red solution pH 4.1 (Sigma). The calcium deposits were
stained orange-red. Slides were imaged under a Leica DMLB
microscope using the Leica Application Suite version 2.7.1
R1 software.
2.8. RNA Isolation, RT and RT-PCR Reactions. Total RNA
was isolated, cDNA was prepared and ampliﬁed as described
previously [8, 16]. Quantitative real-time RT-PCR was
performedusingABIStepOnePlus(AppliedBiosystems,Calif,
USA) as described previously [14, 16, 30]. The primer pairs
and annealing temperatures listed in supplemental material
data 2.
2.9. Immunoﬂuorescence. Human liver cells treated were
plated on glass cover slides in six-well culture plates. Forty-
eight hours later, the cells were ﬁxed and stained as described
previously [16]. The antibodies used in this study are listed
in supplemental material data 1.
The slides were analyzed using a ﬂuorescent microscope
(Provis, Olympus).
2.10. Statistical Analyses. Statistical analyses were performed
using two-sample Students t-test assuming unequal vari-
ances.
3. Results
3.1. Characterization of Human Liver-Derived Cells Cultured
In Vitro . Adult human liver cells can be propagated in vitro
for roughly 20 passages; after an initial 2-week lag, the cells
proliferate at a constant rate (Figure 1(a))[ 14–17]. In addi-
tiontoproliferation,agradualandpartialdecreaseinmature
hepatic characteristics is observed [30]. A comparison of the
gene expression proﬁles of primary cultures of adult human
liver cells (passages 2–4), and the original intact tissues
revealed changes in the repertoire of expressed genes (Figures
1(b) and 1(c)). Human liver-derived cells in culture undergo
dediﬀerentiation, manifested as decreased expression of
numerous adult hepatic markers and increased expression
of immature and endodermal markers (Figure 1(b))[ 30].
Previously, it was reported that hepatic dediﬀerentiation and
downregulation of mature hepatic markers occurs rapidly,
within 24 hours in culture [35]. Our data support that
as the reduction was detected at any time point analyzed
(P0–25 in culture). Despite the massive downregulation
of adult hepatic markers, 88 ± 6% of the liver cells in
culture maintains albumin expression and production, as
demonstrated by ﬂow cytometry and immunoﬂuorescence
(Figures 2(a) and 2(b)). Approximately 60% of the cells in
culture were positive for another adult hepatic marker α-
anti-trypsin (AAT) inhibitor (Figure 2(a)) though at lower
levels than in the intact organ [30]. Twenty percent of
liver cells in culture express the hepatic fetal marker alpha-
fetoprotein (AFP), but none express the hepatic progenitor
marker EpCAM or duct cell markers CA19–9 or CK19
[28, 36, 37]. Taken together, these results suggest that the
proliferating cells in culture may not represent populations
of hepatic stem cells.
Liver cells in culture expressed lower levels of the epithe-
lial marker E-CAD and higher levels of N-CAD compared
to intact liver tissues (Figures 1(c) and 2(a)). Such a switch
in cadherin expression usually characterizes an epithelial to
mesenchymal transition (EMT) process, which also occurs
to pancreatic islet cells in culture [38]. In addition to
the switch in cadherin expression levels, expression of the
transcription factors Snail and Slug was activated, which
further strengthens the notion that proliferating human liver
cells in culture may undergo an EMT process (Figure 1(c)).
To further uncover the nature and properties of liver-
derived cells in in vitro culture, we analyzed the expression
of markers that characterize mesenchymal cells. Cellular
characterization of the cells in increasing passages indicated
that most liver-derived cells in culture express several mes-
enchymalstemcell(MSC)markers,includingCD105,CD90,
CD73, and CD29 (Figures 2(a) and 2(c)). Double immunos-
taining demonstrated the colocalization of hepatic and MSC
markers within the same cells (Figure 2(d)). Hematopoietic4 Journal of Transplantation
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Figure 1: Proliferating adult human liver cells in culture undergo hepatic dediﬀerentiation associated with EMT marker expression. (a)
Growth curve of adult human liver cells supplemented with exendin-4 (5nM) [11]. (b) Quantitative RT-PCR analysis of hepatic (albumin,
ADH1b, GLUL, SMAT5, and AFP), endodermal (GATA4) and (c) EMT (E-CAD, N-CAD, Snail, and Slug) markers in primary cultures of
adult human liver cells (n = 4, P2–4) compared to intact adult human liver tissue (n = 4). The results are normalized to β-actin expression
within the same cDNA sample and presented as the relative levels of the mean ± standard deviation of primary cultures versus liver tissue.
∗P<0.01.
marker expression was not detected in the human liver-
derived cultures (Figure 2(a)). These data suggest that liver-
derived cells in culture coexpress hepatic and general MSC
markers but may not represent a known hepatic progenitor
population, as neither CK-19 nor EpCAM expression is
detected [28, 36, 37].
3.2. Developmental Plasticity of Liver-Derived Cells in Culture.
The MSC markers present on most liver-derived cells in
culture motivated us to analyze whether the cells also
exhibit cellular plasticity. Human liver cells at passage 4
were cultured for 21 days under deﬁned diﬀerentiation
conditions known to activate osteocytes and adipocytes
among BM-derived MSCs (Figures 2(e), 2(f), 2(g),a n d
2(h)). Indeed, human liver cells cultured in adipogenic
diﬀerentiation medium exhibited lipid-containing droplets
visualized by Oil Red staining (Figure 2(e)). Cells cultured in
osteogenic diﬀerentiation media developed calcium deposits
visualized by Alizarin Red staining, which is characteristic of
osteogenic diﬀerentiation (Figure 2(g)). These data indicate
that the liver-derived cells that propagate in vitro acquire
developmental plasticity, which may allow them to diﬀer-
entiate along alternate developmental fates in response to
applied growth and diﬀerentiation conditions. The devel-
opmental plasticity these cells exhibited may provide a
partial explanation of their capacity to acquire a β-cell
phenotype in response to ectopic pancreatic transcription
factor expression.
3.3. Liver-Derived Cells Cultured In Vitro Do Not Induce
Tumors in Immune Deﬁcient Mice In Vivo . The epithelial-
mesenchymal transition in liver has been suggested to
be related to invasiveness and metastatic potential in
mouse and human cancers [39, 40]. Moreover, BM-derivedJournal of Transplantation 5
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Figure 2: Primary adult human liver cell cultures express hepatic and mesenchymal stem-cell markers and diﬀerentiate along adipogenic
and osteogenic lineages. (a) Adult human liver cells (P1–P7, n ≥ 5) were characterized for the expression of speciﬁc surface and intracellular
markers of hepatic, hepatic progenitor, mesenchymal, and hematopoietic lineages by ﬂow cytometry. (b–d) Double immunoﬂuorescent
staining of human liver cells (P7) for albumin and CD90. Nuclei were stained by DAPI (blue). Original magniﬁcation ×20. (e) Liver cells at
P4 were induced to diﬀerentiate toward the adipogenic and (g) osteogenic lineages using the speciﬁc diﬀerentiation cocktails for 21 days in
culture. Control cells in regular cell culture media are shown in (f) and (h). Samples were ﬁxed and stained with Oil Red (adipogenic lipids,
(e), (f) or Alizarin (osteogenic calcium, (g), (h)). Original magniﬁcation ×10.6 Journal of Transplantation
mesenchymal stem cells have been demonstrated to exhibit
tumorigenic capacity upon in vivo implantation [41–43].
Therefore, we analyzed whether the implantation of adult
human liver-derived cells potentially generates tumors in
vivo upon transplantation in immune-deﬁcient mice. Adult
human liver-derived cells at passage 4 were injected subcu-
taneously into both ﬂanks of nude mice (1 × 106 cells per
injection, 5 mice per group, 2 transplantations per mouse)
and tumor growth monitored weekly. Transplantation of
tumor-derived cells, such as MDA-MB 231 or Panc-1 cells,
resulted in large tumor formation 3–6 weeks after implanta-
tion [34], but none of the mice implanted with liver-derived
cellsdeveloped visibletumorsover4 months. After17 weeks,
the mice were sacriﬁced and the area of injection examined.
No traces of the cells were identiﬁed in the specimens. These
data suggest that despite the cellular plasticity manifested
earlier, dediﬀerentiated human liver cells have mesenchymal
characteristics but may not carry a risk of uncontrolled cell
proliferation or tumor formation.
3.4. Irreversible Tracing of Albumin Expression. The adult
human-derived liver cells characterized above were reported
in the past to undergo cellular reprogramming and generate
insulin-producing cells upon ectopic expression of the
pancreatic transcription factor PDX-1 [14, 16, 17, 30].
However, because only a fraction of PDX-1 expressing cells
become insulin positive [14, 16], we sought to analyze
whether the insulin-producing cells are generated from
cells that originally express albumin or a yet unidentiﬁed
side population of stem-like cells that may be enriched
in the hepatic-derived primary cultures. Because PDX-1
turns oﬀ the hepatic repertoire of gene expression [30],
we irreversibly tagged albumin expression prior to PDX-1
treatment. Human liver cells at passages 1–3 were coinfected
b yad u a ll e n t i v i r u ss y s t e mm o d i ﬁ e df r o mR u s se ta l .
[33].ThislentivirussystemincludedtheCMV-loxP-DsRed2-
loxP-eGFP (R/G) reporter [33] and an additional lentiviral
vector carrying the expression of Cre recombinase under
the control of the albumin promoter (ALB-Cre, Figure 3(a)).
R/G treatment resulted in DsRed2, but not eGFP, expression
in 84.1 ± 3.1% of cells. The albumin promoter activates
the expression of Cre recombinase only in albumin-positive
cells. Cre recombinase cleaves the “ﬂoxed” DsRed2, allowing
the constitutive expression of eGFP under the same CMV
promoter (Figure 3) .T h ed u a ll e n t i v i r u ss y s t e me x h i b i t e da
high level of speciﬁcity; no eGFP-positive cells were detected
in non-liver cells,such as pancreaticβTC1 cells (Figures3(e),
3(f),a n d3(g)), and Cre recombinase expression colocalized
with albumin (Figures 3(h), 3(i), 3(j),a n d3(k)). Because
most adult human liver cells express albumin (88 ± 6%,
Figure 2(a)), we expected that the majority of cells infected
by both lentiviruses would have activated Cre recombinase
and become eGFP-positive. The eﬃciency of infection with a
single lentivirus was ∼85%, and double infection resulted in
72% eGFP-positive cells, using CMV-Cre as control. Adult
human liver cells infected with the two-lentivirus system
(R/G and ALB-Cre) resulted in 69.4 ± 7.6% eGFP-positive
cells within ten days of infection, with few cells expressing
both eGFP and DsRed2 protein (Figure 3(d)). Colabeling
with eGFP and DsRed2 likely reﬂects the activity of the
albumin promoter and the relatively long half-life of the
DsRed2 protein (t1/2 = 4.5 days), such that the DsRed2
protein can be detected even 1-2 weeks after the DsRed2
gene is no longer expressed [33]. Only 9.3 ± 5.4% of the
cellsremainedirreversiblypositiveforDsRed2.Thesecells,in
part,representanincapabilitytoactivatealbuminexpression
(about 2%-3%) and/or cells infected only with the reporter
vector CMV-loxP-DsRed2-loxP-eGFP but not by the ALB-
C r el e n t i v i r u sv e c t o r .
3.5. Characterization of Cells Irreversibly Tagged for Albumin
Expression by eGFP. eGFP-labeled liver cells were separated
from DsRed2-positive cells by FACS-Sorter and cultured
separately for several passages (Figures 4(a), 4(b), 4(c),
4(e), and 4(f)). Two weeks after sorting (3 passages), less
than 3% of DsRed2-positive cells were detected among the
eGFP-positive population, the vast majority of which were
colabeled by eGFP (data not shown), suggesting a highly
puriﬁed culture of albumin-positive, eGFP-labeled cells.
The eGFP and DsRed2 populations exhibited distinct
hepatic marker expression. In addition to increased expres-
sion of the albumin gene in eGFP-positive cells(Figure 4(g)),
additional adult hepatic markers, such as ADH1b, GLUL,
andthetranscriptionfactorCEBPβ,wereexpressedtohigher
levels compared to the DsRed2-positive cells (Figure 4(g)).
However, the expression level of the hepatic genes in eGFP-
positive cells was lower than that of cells at passage 2–
4( Figure 1(b)), further suggesting an ongoing dediﬀeren-
tiation process which occurs in culture with time. The
expression of immature or progenitor markers, such as AFP
and CK19, was similarly detected in both groups (data not
shown). In contrary, the DsRed2-positive cells were enriched
for αSMA, desmin, and GFAP expression compared to the
eGFP-positive cells (Figure 4(h)). αSMA, desmin, and GFAP
are typically considered to be hepatic stellate cell markers
[44].Althoughstellatecellsareconsideredmesenchymalcells
[45], they do not usually express the mesenchymal marker
CD90. The fact that DsRed2 cells also expressed αSMA,
desmin, and GFAP but low levels of CD90 (Figure 4(i))
suggests that indeed, the DsRed2 population of cells may
include the hepatic stellate cell population. Flow cytometry
and immunoﬂuorescence conﬁrmed that each of the isolated
eGFP-positive cells expressed albumin, CD105, and CD90
at higher levels than DsRed2-positive cells (Figures 4(j) and
4(k) and data not shown).
3.6. Ectopic PDX-1 Expression Induces Cellular Reprogram-
ming. Next, we sought to analyze which of the two liver cell
populations preferentially support PDX-1-induced repro-
gramming, manifested as induced insulin production. eGFP-
positive cells and DsRed2-positive cells were separately
treated with Ad-PDX-1 and supplemented with soluble
factors as previously described [16]. Ectopic PDX-1 expres-
sion resulted in a signiﬁcant decrease in albumin gene
expression (data not shown) [30]. However, ectopic PDX-1
expression did not aﬀect the expression of CD105 and CD90
in the separate cultures (data not shown). Ectopic PDX-1
expression in eGFP positive cells activated the expressionJournal of Transplantation 7
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Figure 3: Irreversible labeling for albumin expression using the dual lentivirus system (lineage tracing). (a) Schematic presentation of the
lentivirus vectors. (b–d) Adult human liver cells or (e–g) β-TC1 cells were infected with the reporter virus in combination with ALB-Cre
virus. Liver cells were imaged 10 days after infection for DsRed2 (red) or eGFP (green) autoﬂuorescence (original magniﬁcation ×10). (h–k)
Immunostaining of adult human cells infected with both viruses for Cre (blue, (j)), eGFP (green, (i)), and DsRed2 (red, (h)). (k) Merged
image of all stainings. White arrows indicate DsRed2-positive cells. Yellow arrows indicate eGFP and Cre double positive cells. Original
magniﬁcation ×60.
of pancreatic hormones gene expression (INS, GCG, and
SST; Figure 5(a)), the expression of genes involved in β-cell
glucose sensing (GLUT-2, GK), and prohormone processing
(PC2)(Figure 5(b)).Onlytheexpressionofsomatostatinwas
signiﬁcantly activated in DsRed2 positive cells. Moreover,
PDX-1 treatment resulted in insulin production, which
mainly colocalized with eGFP; 17.6 ± 3.5% of eGFP-positive
cells coexpressed insulin (Figures 5(c)–5(h)). In contrast,
only 3.35 ± 2.1% of DsRed2-positive cells was also positive
for insulin in response to a similar reprogramming protocol
(datanotshown).Becauseabout28%oftheDsRed2-positive
cells could have been positive for albumin but not eGFP,
the actual percentage of insulin-positive cells generated in
a l b u m i n - n e g a t i v eh u m a nl i v e rc e l l si se v e nl o w e rt h a n3 . 3 5±
2.1%. Taken together, these data suggest that albumin-
positive cells represent the vast majority of liver cells that
undergo reprogramming along the pancreatic lineage.
4. Discussion
Using a genetic lineage-tracing approach, we demonstrate
for the ﬁrst time that the insulin-producing cells induced
by ectopic expression of the pancreatic transcription fac-
tor PDX-1 in human liver cells mainly originate from8 Journal of Transplantation
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Figure 4: Isolated cultures of eGFP-positive cells express hepatic markers. Adult human liver cells were infected with the reporter virus
and ALB-Cre virus. Two weeks later, eGFP-positive and DsRed2-positive cells were separated using a cell sorter. The eGFP-positive (a–c)
and DsRed2-positive (d–f) cells were separately cultured and imaged 24 hours later for eGFP ((a) and (d), green) and DsRed2 ((b) and
(e), red) ﬂuorescence. (c and f) eGFP and DsRed2 merge images. Original magniﬁcation ×20. Quantitative RT-PCR in eGFP-positive cells
compared to DsRed2-positive cells using mRNA extracted 2 weeks after sorting of (g) hepatic (albumin, ADH1b, GLUL, and CEBPβ), (h)
stellate cell (SMA, desmin, and GFAP), and (i) mesenchymal stem cell (CD105, CD29. CD90, and CD73) marker expression. The results
were normalized to β-actin expression within the same cDNA sample and presented as the relative levels of the mean ± standard deviation
of DsRed2-positive versus eGFP-positive cells, n = 6f r o m3d i ﬀerent cultures. ∗P<0.01, ∗∗P<0.05. (j) The expression of the mesenchymal
marker CD105 was analyzed in the eGFP and (k) DsRed2-positive cells by ﬂow cytometry.Journal of Transplantation 9
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Figure 5: Ectopic PDX-1 expression induced pancreatic diﬀerentiation mainly in eGFP positive liver cells. eGFP-positive cells and DsRed2-
positivecellsweretreatedwithAd-PDX-1andsolublefactorsfor5days.QuantitativeRT-PCRanalysisof(a)pancreatichormones(INS,GG,
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Ad-PDX-1 treated eGFP-positive liver cells. Original magniﬁcation ×20 (c–e) and ×60 (f–h). Five hundred cells were analyzed under the
ﬂuorescent microscope for eGFP, DsRed2, or insulin in three diﬀerent cultures.
albumin-positive cells. The proliferating adherent human
liver cells express both adult liver and mesenchymal cell
markers and possess a considerable level of developmental
plasticity (Figures 1 and 2).
Most liver-derived cells in the primary culture express
mesenchymal characteristics (Figure 2). The origin of these
hepatic MSC-like cells is not clear; they could represent
liver cells that underwent EMT, or the cells may represent a
preexisting population of stem-like cells with self-replication
capacity, which normally serve as hepatic progenitor cells.
Theprecisecombinationofmarkersthatcharacterizehuman
hepatic progenitor cells is controversial [29]; thus, it is
complicated to completely rule out the possibility that
our culture conditions promoted the ampliﬁcation of pre-
existing human hepatic stem-like cells. However, the com-
prehensive characterization of the primary culture of the
human liver-derived cells seems to favor the option that
insulin-producingcellsaregeneratedindediﬀerentiatedliver
cells that underwent an EMT process, meaning that such
cells, most likely, do not exist in the intact organ. This10 Journal of Transplantation
conclusion is based on several lines of evidence. First, 88%
of the cells in culture are not only positive for albumin,
but the albumin-positive cells also express higher levels of
other adult hepatic markers, which is not expected to occur
in pluripotent stem-like cells. Second, EpCAM is agreed
upon as being a hepatic progenitor marker and is not
expressed in our human-derived cells. Third, the only cells
in the intact adult liver with mesenchymal characteristics
are stellate cells. However, stellate cell marker expression was
low in general and occurred mainly in the albumin-negative
population, which had lower reprogramming eﬃciency
(Figure 4(h)). Taken together, these data may suggest that
the cells populating the majority of human liver-derived
primary culture are not residents of the intact organ that
underwent preferential proliferation. On the other hand,
our human liver-derived primary culture exhibits several
EMT characteristics, including speciﬁc mesenchymal marker
expression (Figures 1 and 2), decreased E-CAD associated
with increased N-CAD expression (Figure 1(b)), and the
activation of Snail and Slug expression, the zinc ﬁnger
transcription factors known to control the EMT process
(Figure 1(c))[ 40, 46].
Epithelial to mesenchymal transition is a common
process that epithelial cells undergo upon in vitro cul-
ture [47–49]. In vivo,E M Tp l a y sak e yr o l ei nm o r -
phogenic changes during embryonic development, wound
healing/tissue regeneration, and neoplasia [25, 26, 30]. Sev-
eral groups have demonstrated that the process is associated
with the downregulation of epithelial gene expression and
activation of mesenchymal gene expression [47–49]. EMT
induction in vitro has been suggested in cultured thyroid
cells [50] and adult human islets upon entrance into the cell
cycle [51]. More recently, direct evidence of EMT in cultured
adultprimaryβ-cellswasdemonstratedusinggeneticlineage
tracing [38]. The capacity of adult parenchymal liver cells to
give rise to insulin-producing cells is further strengthened
by in vivo studies. Direct administration of PDX-1 in
mice in vivo suggests that the insulin-producing cells are
primarily generated in parenchymal cells close to the central
veins [8, 11, 25]. Hepatic pericentral cells are suggested
adult,terminallydiﬀerentiated,whileadulthepaticstemcells
mainlyresideinperiportalareasoftheliverandintheCanals
of Hering [22]. While these observations need to be directly
analyzed by a lineage tracing approach, they suggest that the
reprogrammingprocessdoesnotprimarilytakeplaceinbona
ﬁde adult hepatic stem cells.
Despite the uniform morphology of the human liver-
derived cells in vitro, the cells seem to maintain diﬀerent
phenotypes with regard to albumin and the expression
of other adult hepatic markers, which may correlate with
distinct reprogramming capacity. Using irreversible lineage
tracingforalbuminpromoteractivity,wepresentsupporting
evidence that insulin-positive cells induced by ectopic PDX-
1 expression are preferentially generated in cells that are
originallyalbumin-positive(Figure 5).Inarecentpaper,Dan
et al. [28] isolated human hepatic progenitor cells that carry
the capacity to diﬀerentiate along multiple hepatic lineages,
including mesenchymal cells. However, these cells did not
express albumin. The colocalization of albumin expression
withmesenchymalmarkerssuggeststhatthereprogramming
processoflivertopancreasdoes notoccurinsuchcellsbutin
hepatic dediﬀerentiated cells [30], which undergone an EMT
process.
Because we also detected a small number of insulin-
positive cells among the DsRed2-positive cells, we can-
not rule out the possibility that nonalbumin-positive cells
present in our culture underwent reprogramming and
contributed to the insulin-producing cell population but
with lower reprogramming eﬃciency.
The fact that the special mesenchymal cells coexpressing
albumin do not induce tumors in immune-deﬁcient rodents
conveys a substantial safety advantage over using other
progenitor cells in tissue engineering approaches [52, 53].
By contrast, other mesenchymal cells derived from bone
marrow have been documented in numerous studies to carry
a tumorigenic potential under similar conditions [41–43].
The data generated in this study provide a better
understanding of the nature of primary human liver cell
culture, which is capable of undergoing pancreatic transcrip-
tion factor-induced reprogramming. Further dissection of
subpopulations of cells within the liver-derived, albumin-
positive mesenchymal cells will allow us to identify the
speciﬁc characteristics of liver cells, which are predisposed
to reprogramming to allow a substantial increase in the
eﬃciencyofthereprogramming processalongthepancreatic
lineage.
5. Conclusion and Summary
The present study suggests that the insulin-producing cells
inducedbyectopicexpressionofthepancreatictranscription
factor PDX-1 in human liver cells mainly originate from
albumin-positive cells. The proliferating adult human liver
cells in culture acquire mesenchymal characteristics and a
highlevelofcellularplasticity.However,whilemostlivercells
in culture possess mesenchymal-like characteristics, insulin
production is induced in albumin positive cells, which are
enriched for adult hepatic markers expression. Identiﬁcation
and the characterization of cells prone to reprogramming
along the β-cell lineage is expected to increase the repro-
gramming eﬃciency. It may allow developing controlled and
reproducible reprogramming process, by overcoming the
pronounced heterogeneity of cells in the primary cultures.
R e p r o g r a m m i n gl i v e rt op a n c r e a so ﬀers the access to an
abundant source of “self-tissue”. The approach obviates the
shortage in tissue availability from cadaveric donors and
the need for antirejection treatment, allowing the diabetic
patient to be the donor of his own therapeutic tissue.
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